Inconsistencies in laboratory investigations of hypertension in a young woman taking ethinylestradiol/drospirenone association.

Patrice DufourLaurent VroonenCavalier EtienneCaroline Le Goff

Published in: Acta clinica Belgica (2022)

Considering the data in the literature and our clinical case, we suggest adding drospirenone and the ethinylestradiol/drospirenone association in the list of drugs interfering with aldosterone and renin level determination.

Keyphrases

blood pressure
systematic review
electronic health record
big data
machine learning
angiotensin ii
high resolution
mass spectrometry
deep learning